关键词: 无乳链球菌, 泌尿生殖道, 耐药性

Abstract:

Objective To analyze retrospectively the drug resistance of Streptococcus agalactiae isolated from female urogenital tract, to understand the drug resistance tendency change of commonly-used antibiotics, and to guide the rational use of antibiotics in clinical application. Methods The routine culture was performed for female urogenital tract specimens collected from January 2009 to December 2012, and the identification and drug sensitivity test were performed for Streptococcus agalactiae by VITEK32 automatic bacterium identification analyzer. The D-inhibition zone trial was tested for isolates which were drug-resistant to erythromycin and sensitive or intermediary to clindamycin. Results There was a statistical significance in age distribution among 569 specimens from Department of Gynecology and 192 specimens from Department of Obstetrics (P<0.01). Drug resistance rate was 0 to vancomycin and <3% to penicillin and linezolid. The drug resistance rate of nitrofurantoin was <0.5% from 2009 to 2011 and suddenly increased to 7.2% in 2012. The drug resistance rate of tetracycline exceeded 90%. Erythromycin, clindamycin and levofloxacin reflected high drug resistance rates and such an increasing tendency year by year. The positive rate of D-inhibition zone trial was 21.7%. Conclusions It is required to rationally use antibiotics in clinical application according to the drug sensitivity test results. Meanwhile, the drug resistance monitoring in clinical application should be strengthened.

Key words: Streptococcus agalactiae, Urogenital tract, Drug resistance